Pharmacological treatment of children and adolescents with mental health conditions

Pharmacological treatment of children and adolescents with mental health conditons

This survey can be answered by a parent,  or by a child/young person (until the age of 18) with supervision of a parent, or both (one survey completed by the parent and one survey completed by the child/young person). As part of the ECNP Child and Adolescent Psychopharmacology Network, (https://www.ecnp.eu/research-innovation/networks-thematic-working-groups/List-ECNP-Networks/Child-and-adolescent-neuropsychopharmacology), concerned with setting the ground for development, implementation and education regarding neuropsychopharmacology in children and adolescents, we are developing a paper focusing on Psychopharmacology in children and adolescents: unmet needs and opportunities.
To gather patients’ and parents' perspectives, that are usually lacking in reviews of this kind, we would like to invite you to complete the following brief questionnaire (3 questions). We are very thankful for your participation, that will allow us to raise awareness regarding relevant aspects and to enhance the quality and the potential impact of this work.  
1.What information would you like to see from future studies on the pharmacological treatment of children and adolescents with mental conditions?
2.Do you think there is stigma related to the pharmacological treatment of children and adolescents with mental health conditions?
3.If so, how can we tackle it?
4.This survey has been completed by (you can choose one or both)